F. Baldinetti

SMA – THERAPY

Eugenio Mercuri, G. Baranello, R. Masson, Odile Boespflug‐Tanguy et autres

it, fr, be, gb, us (code pays fourni par la source)

Onasemnogene Abeparvovec-xioi Gene Therapy in Presymptomatic Spinal Muscular Atrophy (SMA): SPR1NT Study Update

K. Strauss, Michelle A. Farrar, Kathryn J. Swoboda, Kayoko Saito et autres

Onasemnogene abeparvovec gene-replacement therapy (GRT) for spinal muscular atrophy type 1 (SMA1): Global pivotal phase 3 study program (STR1VE-US, STR1VE-EU, STR1VE-AP)

Eugenio Mercuri, Giovanni Baranello, John Day, Claudio Bruno et autres

it, us, jp, gb (code pays fourni par la source)

Onasemnogene abeparvovec gene-replacement therapy (GRT) in presymptomatic spinal muscular atrophy (SMA): SPR1NT study update

K. Strauss, Kathryn J. Swoboda, Michelle A. Farrar, HJ McMillan et autres

us, au, ca, jp, gb (code pays fourni par la source)

Effectiveness and Tolerability of Colesevelam HCl for Accelerated Elimination of Teriflunomide in Healthy Participants

Catherine Lunven, Zuyu Guo, Sandrine Turpault, A. Delfolie et autres

fr, us (code pays fourni par la source)

Dried Blood Spot Methodology in Combination With Liquid Chromatography/Tandem Mass Spectrometry Facilitates the Monitoring of Teriflunomide

Aziz Filali‐Ansary, Catherine Lunven, Sandrine Turpault, Yann-Joel Beyer et autres

fr, us (code pays fourni par la source)

A Phase 3b/4 Long-Term Study of Alemtuzumab in Patients With Relapsing-Remitting Multiple Sclerosis: TOPAZ Study Design (P7.219)

Vesna Brinar, Gavin Giovannoni, Eva Havrdová, Cary Twyman et autres

hr, gb, cz, us, de (code pays fourni par la source)

Evaluation of Comprehensive Alemtuzumab Infusion Guidance in Patients With Relapsing-Remitting Multiple Sclerosis: EMERALD Study Design (P7.283)

Patrick Vermersch, Rafael Arroyo-González, Óscar Fernández, F. Baldinetti et autres

fr, es, ch, us, be (code pays fourni par la source)

Erratum to “Add-on treatment with pregabalin for partial seizures with or without generalisation: Pooled data analysis of four randomised placebo-controlled trials” [Seizure: European Journal of Epilepsy 18 (2009) 184–192]

António Gil‐Nagel, Gaetano Zaccara, F. Baldinetti, Teresa León

es, us (code pays fourni par la source)

Efficacy of pregabalin and venlafaxine-XR in generalized anxiety disorder: results of a double-blind, placebo-controlled 8-week trial

Siegfried Kasper, Barry K. Herman, Giancarlo Nivoli, Michael Van Ameringen et autres

at, us, it, ca, de (code pays fourni par la source)

Add-on treatment with pregabalin for partial seizures with or without generalisation: Pooled data analysis of four randomised placebo-controlled trials

António Gil‐Nagel, Gaetano Zaccara, F. Baldinetti, Teresa León

es, us (code pays fourni par la source)

Efficacy and safety of pregabalin in elderly people with generalised anxiety disorder

Stuart Montgomery, Krai Chatamra, L. Pauer, Ed Whalen et autres

gb, us (code pays fourni par la source)